- Review
Maximal Androgen Blockade for the Treatment of Metastatic Prostate Cancer—A Systematic Review
- H. Lukka,
- T. Waldron,
- L. Klotz,
- E. Winquist,
- J. Trachtenberg and
- on behalf of the Genitourinary Cancer Disease Site Group of the Cancer Care Ontario Program in Evidence-Based Care
Introduction: Maximal androgen blockade (mab) versus castration alone in patients with metastatic prostate cancer has been extensively evaluated in randomized trials. The inconsistent results have led to the publication of multiple meta-analyses. The...

